<!DOCTYPE html>
<html>
<head>
	<title>Hyperthyroidism</title>
	<link rel="shortcut icon" href="images.ico" type="image/x-icon">
	<meta charset="utf-8">
	<!--import CSS-->
	
	<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">

	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">

	<link rel="stylesheet" href="navbar-fixed-side.css" type="text/css">

	<link rel="stylesheet" href="progress-tracker.css" type="text/css">

	<link rel="stylesheet" href="mystyle.css" type="text/css">
	<!--import javascript-->
	<script src="https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js" type="text/javascript"></script>

	<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" type="text/javascript"></script>

	<script src="myscript.js" type="text/javascript"></script>
</head>
<body onload="locateMe(); checkcurrentlevel();">
<!--Auto open The Modal-->

	<div class="container-fluid">
	  <div class="row">
	    <div class="col-sm-4 col-lg-3">
	      <nav class="navbar navbar-default navbar-fixed-side">
	        <div class="" style="padding-left:20px">
		        <h3 style="color:black">Hyperthyroidism</h3>

		        <ul class="progress-tracker progress-tracker--vertical">
		        	<!--<li class="progress-step is-complete">-->
		          <li class="progress-step is-active"  >
		            <a href="index.html" id="pa1">
		            <span class="progress-marker"></span>
		            </a>
		            <span class="progress-text">
		            	<a href="index.html" id="pb1">
		              		<h4 class="progress-title" id="p1">What is hyperthyroidism?</h4>
		              	</a>
		            </span>
		          </li>
		          
		          <li class="progress-step is-active">
		          <a href="page2.html" id="pa2">
		            <span class="progress-marker"></span>
		          </a>
		            <span class="progress-text">
		            	<a href="page2.html" id="pb2">
		              		<h4 class="progress-title" id="p2">Treatment Options</h4>
		              	</a>
		            </span>
		          </li>
		          
		          <li class="progress-step is-active">
		          	<a href="page3.html" id="pa3">
		            	<span class="progress-marker"></span>
		            </a>
		            <span class="progress-text">
			            <a href="page3.html" id="pb3">
			              <h4 class="progress-title" id="p3">Pros and cons</h4>
			            </a>
		            </span>
		          </li>
		          
		          <li class="progress-step">
		          	<a href="page4.html" id="pa4" >
		            	<span class="progress-marker"></span>
		            </a>
		            <span class="progress-text">
		            	<a href="page4.html" id="pb4">
		              		<h4 class="progress-title" id="p4">What is important to you?</h4>
		              	</a>
		            </span>
		          </li>
		          <li class="progress-step">
		          	<a href="page5.html" id="pa5">
		            	<span class="progress-marker"></span>
		            </a>
		            <span class="progress-text">
		            	<a href="page5.html"  id="pb5">
		              		<h4 class="progress-title" id="p5">Do you need more support?</h4>
		              	</a>
		            </span>
		          </li>
		          <li class="progress-step">
		          	<a href="page6.html"  id="pa6">
		            	<span class="progress-marker"></span>
		            </a>
		            <span class="progress-text">
			            <a href="page6.html" id="pb6">
			              <h4 class="progress-title" id="p6">Making a Choice</h4>
			            </a>  
		            </span>
		          </li>
		          <li class="progress-step">
		          	<a href="page7.html"  id="pa7">
		            	<span class="progress-marker"></span>
		            </a>
		            <span class="progress-text ">
		            	<a href="page7.html"  id="pb7">
		              		<h4 class="progress-title" id="p7">Print PDF</h4>
		             	</a>
		            </span>
		          </li>
		        </ul>

		      </div>
	      </nav>
	    </div>
	    <div class="col-sm-8 col-lg-9">
	      <!--page content -->
	      <div class="header" id="Definition">
		      <h1 class="heading">Pros and Cons of Each Treatment Option</h1>
		  </div>
            <div class="tablecontent" id="compare">
				<table class="table table-striped mytable table-bordered">
  					<thead class="thead-inverse">
    					<tr>
			      			<th> </th>
			      			<th class="plans">Anti-thyroid drugs</th>
      						<th class="plans">Radioactive Iodine</th>
      						<th class="plans">Thyroidectomy</th>
    					</tr>
  					</thead>
  					<tbody>
    					<tr>
      						<th scope="row">Thyroid hormone control</th>
      						<td>
    			  				<ul class="comparetable fastanim">
                                    <li class="space"><b>Avoid long term hypothyroidism</b> (permanently low levels of thyroid hormones)</li>
      								<li class="space"><b>Risk of hyperthyroidism relapse. </b> About <b>1 in 2</b> people on oral medication will get a relapse of hyperthyroidism. </li>
      							</ul> 
      						</td>
      						<td>
      							<ul class="comparetable fastanim">
                                    <li class="space"><b>Permanent remission (stop) of hyperthyroidism.</b> With adjustment and monitoring of your oral thyroxine doses, you can achieve normal thyroid hormone levels.</li>
                                    <li class="space">You will have permanent hypothyroidism <b>requiring lifelong oral thyroxine hormone and annual T4 blood test monitoring</b> (the test for thyroid hormone levels)</li>
			      				</ul> 
      						</td>
     			 			<td>
      							<ul class="comparetable fastanim">
                                    <li class="space"><b>Permanent remission (stop) of hyperthyroidism.</b> With adjustment and monitoring of your oral thyroxine doses, you can achieve normal thyroid hormone levels.</li>
 			     					<li class="space">You will have permanent hypothyroidism <b>requiring lifelong oral thyroxine hormone and annual T4 blood test monitoring</b> (the test for thyroid hormone levels)</li>
                                    <li class="space"><b>Recurrent (relapse) hyperthyroidism</b> in <b>2 out of 100</b> patients who undergo surgery; <b>98 out of 100</b> do not get this. </li>
      							</ul> 
 			     			</td>
    					</tr>
    					<tr>
      						<th scope="row">Cost of treatment</th>
    		  				<td>
      							<ul class="comparetable slideanim">
      								<li class="space">Cheapest option.</li>
      							</ul>
  		    				</td>
      						<td></td>
      						<td>
      							<ul class="comparetable slideanim">
 		     						<li class="space">Expensive Cost.</li>
      							</ul>
      						</td>
    					</tr>
                        <tr>
      						<th scope="row">Risk of side effects</th>
    		  				<td>
      							<ul class="comparetable slideanim">
      								<li class="space"><b>Risk of minor allergic side effects such as rashes.</b><br><br><b>5 out of 100 </b>patients get this; <b>95 out of 100</b> do not.</li>
      							</ul>
  		    				</td>
      						<td>
     		 					<ul class="comparetable slideanim">
                                    <li class="space"><b>Loss of taste and dry mouth</b> due to salivary gland damage may happen.</li>
                                </ul>
 		     				</td>
      						<td>
      							<ul class="comparetable slideanim">
 		     						<li class="space"><b>Risk of transient (temporary) vocal cord paralysis.</b><br><br><b>3 out of 100 </b>patients who undergo surgery; <b>97 out of 100</b> do not get this.</li>
      							</ul>
      						</td>
    					</tr>
                        <tr>
      						<th scope="row">Risk of serious medical conditions</th>
    		  				<td>
      							<ul class="comparetable slideanim">
      								<li class="space"><b>Risk of agranulocytosis</b> (a serious condition with a severe decrease in the production of white blood cells). <br><br>For patients receiving <b>propylthiouracil</b>: <b>37 out of 10000</b> get this (<b>9963 out of 10000</b> do not get it)<br><br>For patients receiving <b>methimazole</b>: <b>35 out of 10000</b> receiving  get this (<b>9965 out of 10000</b> do not).</li>
                                    <li class="space"><b>Risk of serious life-threatening allergic skin condition</b> called Steven-johnson syndrome. <b>45 out of 10000</b> patients get this; <b>9955 out of 10000</b> do not.</li>
      							</ul>
  		    				</td>
      						<td>
     		 					<ul class="comparetable slideanim">
                                    <li class="space"><b>Risk of Graves’ ophthalmopathy</b> (a condition affecting the area around your eye, where the eyelids retract and the eyes appear to bulge out). <br><br>This condition happens in <b>15 out of 100</b> patients who use RAI (and does not happen in <b>85 out of 100</b>). <br><br>For patients with <b>existing Graves’ ophthalmopathy</b>, the condition worsens in <b>36 out of 100</b>; <b>64 out of 100</b> do not get worse.</li>
                                    <li class="space">There is a <b>slight increase risk of cancer</b> after exposure to radioactive iodine. <b>154 out of 10 000</b> people treated with RAI develop cancer compared to <b>126 out of 10 000</b> who are not treated with RAI. </li>
                                </ul>
 		     				</td>
      						<td>
      							<ul class="comparetable slideanim">
 		     						<li class="space"><b>Prolonged postoperative hypocalcemia</b> (low calcium levels in <b>3 out of 100</b> patients who undergo surgery; <b>97 out of 100</b> do not get this.</li>
                                    <li class="space"><b>Permanent hypoparathyroidism</b> (low levels of the parathyroid hormone, which regulates calcium absorption) in <b>1 out of 100</b> patients who undergo sugery; <b>99 out of 100</b> do not get this.</li>
      							</ul>
      						</td>
    					</tr>
                        <tr>
      						<th scope="row">Treatment precautions</th>
    		  				<td></td>
      						<td>
     		 					<ul class="comparetable slideanim">
                                    <li class="space">You will have to comply with <b>strict radiation precaution rules for about 1-5 days</b> (e.g. keeping a distance from children and pregnant women, sleeping in separate beds).</li>
                                </ul>
 		     				</td>
      						<td>
      							<ul class="comparetable slideanim">
 		     						<li class="space">You would have to <b>rest after the surgery</b> and may be on <b>medical leave for 1-2 weeks.</b></li>
      							</ul>
      						</td>
    					</tr>
  					</tbody>
				</table>
			</div>
		    </div>
				<br />
				<br />
				<div class="row">
					<div class="col-sm-8"></div>
					<div class="col-sm-2">
					<button class="btn btn-danger" id="btn-prev" onclick="prev()"><i class="fa fa-arrow-left" aria-hidden="true"></i> Previous</button>	
					</div>
					<div class="col-sm-2">
					<button class="btn btn-primary" id="btn-next" onclick="next()">Next <i class="fa fa-arrow-right" aria-hidden="true";></i></button>
					</div>
				</div>
				<div class="col-sm-4 col-lg-3"></div>
				<div class="col-sm-8 col-lg-9" id="foo">
				<div class="footer-bottom" id="foot">

			  
			    <div class="row footer">
			      <div class="column span-3">
			      <div class="col-sm-1" ></div>
			        <div class=col-sm-4>
			        	<p><strong>UNIVERSITY OF MALAYA</strong><br />
			        	Dr. Lee Yew Kong,<br />
						Department of Primary Care Medicine,<br/>
						Faculty of Medicine,<br/>
						University of Malaya,<br/>
						50603 Kuala Lumpur,<br/>
						Malaysia.<br />
						<strong>Email:</strong>
						leeyk@um.edu.my<p>
						</p>
			        </div>
			        
			      </div>
			    </div>
			    <div class="row">
			    	<div class="col-sm-1" ></div>
			      <div class="col-sm-6">
			        <div class="copyright">
			          © 2017, FCSIT,University of Malaya, All rights reserved
			        </div>
			      </div>
			        <div class="design col-sm-3">

			           <a href="#">Group 5 </a> |  <a target="_blank" href=#>Made with Love</a>

			        </div>
			    </div>
			</div>
	    </div>
	  </div>
	</div>
</body>
</html>